Kennard William E 4
4 · METLIFE INC · Filed Apr 3, 2026
Research Summary
AI-generated summary of this filing
MetLife (MET) Director William Kennard Receives 721-Share Award
What Happened William E. Kennard, a non-management director of MetLife, received an award/acquisition of 721 shares of MetLife common stock on 2026-04-01 at a reported price of $71.17 per share, valued at $51,314. This was a grant under director compensation arrangements (transaction code A), not an open-market purchase or sale.
Key Details
- Transaction date: 2026-04-01; Filing date: 2026-04-03 (filed within the typical Form 4 reporting window).
- Shares/price/value: 721 shares at $71.17 per share; total $51,314.
- Transaction type: Award/grant (A) — part of non-management director retainer compensation.
- Shares owned after transaction: Not specified in the provided filing excerpt.
- Footnotes: F1 — Director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors. F2 — Filing notes some shares are held in trust under the MetLife Policyholder Trust for eligible policyholders.
- No indication of a 10b5-1 plan, option exercise, sale, or tax withholding in the provided data.
Context This was compensation-related share issuance to a non-management director and was deferred under MetLife’s director deferred compensation plan (routine director pay). Such awards are standard for board compensation and do not by themselves signal the director buying or selling stock for investment reasons.
Insider Transaction Report
- Award
Common Stock
[F1]2026-04-01$71.17/sh+721$51,314→ 46,501 total
- 10(indirect: By Trust)
Common Stock
[F2]
Footnotes (2)
- [F1]MetLife, Inc.'s non-management director compensation arrangements pay a portion of non-management director retainer fees in MetLife, Inc. common stock. The director elected to defer receipt of these shares under the MetLife Deferred Compensation Plan for Non-Management Directors.
- [F2]Shares held in trust under the MetLife Policyholder Trust established to hold shares of common stock allocated to eligible policyholders of Metropolitan Life Insurance Company, a wholly-owned subsidiary of MetLife, Inc.